Bridging the Gaps in Access to Essential Medicines

Access to essential medicines remains uneven worldwide. A study in India’s aspirational districts showed encouraging progress, with most treatments affordable and widely available. In stark contrast, Sudan’s civil war has led to severe shortages and unaffordable prices, leaving many without life-saving drugs. Meanwhile, Brazil continues to face systemic barriers, economic inequalities, import dependence, and limited ...

The Global Challenge of Poor-Quality Medicines in LMICs

A recent chapter titled “The Current Situation of Medicines Quality in Low- and Middle-Income Countries: New Challenges to be Addressed” (IntechOpen, 2025) sheds light on a growing global health concern: 10.5% of medicines worldwide are of poor quality, with the greatest impact seen in low- and middle-income countries. Harsh climates, weak regulatory systems, and fragmented supply ...

Why QCP Matters

Having a GSDP, GMP, or MQAS assessment is not just a box-ticking exercise; it is essential to ensure that your pharmaceutical systems meet internationally recognised standards of quality and safety. These assessments are critical for building trust, protecting patients, and strengthening your position in the market. The Quamed Quality Certification Program (QCP) is significant because ...

Barriers & Solutions Workshop on Local Procurement in Kabul

Today in Kabul, the Quamed and Relief International team conducted our Barriers & Solutions Workshop, focused on how to best facilitate local procurement of quality medical products in Afghanistan. Internet was still offline, which impeded registered turnout, but we had vibrant interactive discussions with over 35 external participants, with an even mix between government authorities, ...

Working Together for Quality Medicines

From September 9 to 11, 2025, we had the privilege of facilitating a World Health Organisation workshop in Brazzaville, Republic of the Congo, focused on capacity building in quality assurance for the Procurement of Medical Products. Together with WHO AFRO, WHO HQ, and our QUAMED team, we worked with 25 participants from WHO regional and ...

Rafaella’s Literature Update

The following message is courtesy of Dr. Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium Dear Friends, The safe elimination of pharmaceutical (and laboratory!) waste is a critical component of the pharmaceutical life cycle, but it remains, at best, an afterthought for funders, researchers and policymakers, leaving many communities exposed to preventable ...

SIMBLE Stakeholders Meeting on Local Biomedical Manufacturing in Benin

On Thursday, I participated in the SIMBLE stakeholders meeting on “LOCAL MANUFACTURING OF BIOMEDICAL PRODUCTS FOR CLINICAL BACTERIOLOGY IN RESOURCE-LIMITED SETTINGS” in Benin. Thanks to #liselottehardy, #barbarabarbé and #dissouaffolabi for the interesting content, the inspiring discussions and the great organisation. Following the meeting, I met with #ovidegouton and #EricAhognignon to discuss the costs involved in ...

Quamed Renews BSI Certification: A Continued Mark of Trust

We are proud to share that Quamed has officially renewed its BSI Certification ISO9001 with an expanded scope.  It is a true mark of trust and quality recognised worldwide. This milestone reflects our unwavering commitment to excellence, transparency, and the highest standards in everything we do. Earning this certification isn’t just about a logo on our ...

WHO Toolkit Launch: Fighting Fake & Substandard Medicines

Dear Friends, With apologies for any double-posting, we would like to share the WHO invite for the launch of the WHO training toolkit on substandard and falsified (SF) medical products: Note that the webinar will be only in English. With warmest greetings, Raffaella & Belen

Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.